IDiyas

For the Inventor, By the Inventor

South San Francisco, CA, United States of America

Applied Molecular Transport Inc.


USPTO Granted Patents = 18



Forward Citations = 122

Loading Chart...
Loading Chart...

25 inventors (with patents filed for the assignee):

goldMedal Randall J Mrsny (18 out of 28 patents)

silverMedal Tahir Mahmood (17 out of 20 patents)

bronzeMedal Weijun Feng (8 out of 8 patents)

4.  Sally Rhiannon Postlethwaite (7 out of 14 patents)

5.  Charles Olson (5 out of 5 patents)

6.  Thomas Carl Hunter (3 out of 3 patents)

7.  Marvin R Garovoy (2 out of 14 patents)

8.  Amir Porat (2 out of 2 patents)

9.  Khushdeep Mangat (2 out of 2 patents)

10.  Kevin Yin (2 out of 2 patents)

11.  Bittoo Kanwar (2 out of 2 patents)

12.  Hyojin Kim (2 out of 2 patents)

13.  Rajendra Tandale (2 out of 2 patents)

14.  Derek Maclean (2 out of 19 patents)

15.  Sean Dalziel (2 out of 30 patents)


18 patents:

1. 11504433 - Cholix-derived carriers for oral delivery of heterologous payload (2022-11-22),
2. 11479593 - Compositions, formulations and interleukin production and purification (2022-10-25),
3. 11466067 - Compositions, formulations and interleukin production and purification (2022-10-11),
4. 11426466 - Toxin-derived delivery constructs for pulmonary delivery (2022-08-30),
5. 11324833 - Cholix-derived carriers for oral delivery of heterologous payload (2022-05-10),
6. 11246915 - Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo (2022-02-15),
7. 11214606 - Compositions, formulations and interleukin production and purification (2022-01-04),
8. 11160869 - Compositions, formulations and interleukin production and purification (2021-11-02),
9. 11027020 - Delivery constructs for transcytosis and related methods (2021-06-08),
10. 10799565 - Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo (2020-10-13),
11. 10786556 - Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo (2020-09-29),
12. 10786555 - Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo (2020-09-29),
13. 10624956 - Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo (2020-04-21),
14. 10624955 - Cholix toxin-derived fusion molecules for oral delivery of biologically active cargo (2020-04-21),
15. 10617767 - Compositions and methods for oral delivery of therapeutic cargo (2020-04-14),
Applied Molecular Transport Inc. (AMT) is a biopharmaceutical company focused on utilizing its proprietary technology platform to develop novel oral therapies for serious diseases. The company's platform enables the oral delivery of biologics, which are typically administered through injections. AMT's innovative approach aims to improve patient outcomes and increase treatment accessibility through convenient and effective oral drug delivery. Learn more about Applied Molecular Transport Inc. and its groundbreaking research at their official website.
This text is generated by artificial intelligence and may not be accurate.

logo

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

18 Patents

#68 in South San Francisco, CA

#4,145 in California

#17,382 in US

#33,147 in the World

...
South San Francisco, CA, United States of America

Applied Molecular Transport Inc.

Forward Citations = 122

25 inventors:

goldMedal Randall J Mrsny (18 out of 28 patents)

silverMedal Tahir Mahmood (17 out of 20 patents)

bronzeMedal Weijun Feng (8 out of 8 patents)

4.  Sally Rhiannon Postlethwaite (7 out of 14 patents)

5.  Charles Olson (5 out of 5 patents)

Please report any incorrect information to support@idiyas.com
Loading…